Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on h…
Established
18
Citations20
Refs1994
Year
Search Works
Work Details
- PMID https://pubmed.ncbi.nlm.nih.gov/8062267
- OpenAlex ID W1924659121
- Type Article
- Language EN
- Published 01 Sep 1994
- Volume 54 (17)
- Pages 4698–702
- Source PubMed
- Publisher National Institutes of Health
- FWCI 1.27
- Countries 1
- Institutions 1
- Added 24 Jun 2016
- Updated 31 Oct 2026
External Links
MENU
0
Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts.
Article 1994 EN
The polyamine analogue 1,19-bis(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4), 5 mg/kg i.p., was given twice daily on days 0-3 and 7-10 (cycle 1) to nude mice with human malignant gliomas (SF-767 and U-87 MG), lung adenocarcinoma (A549), and colon carcinomas (HCT116 and HT29). A second cycle of drug was given to mice with SF-767 and A549 tumors on days 42-45 and 49-52. The maximum animal weigh…
18
Citations
20
References
7
Authors
1.27
FWCI
Topics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
7 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | M. Eileen Dolan | University of Chicago Medical … (US) | |
| 2 | Matthew F. Fleig | — | — |
| 3 | Burt G. Feuerstein | — | |
| 4 | Hirak S. Basu | — | |
| 5 | G D Luk | — | — |
| 6 | Robert A. Casero | — | |
| 7 | L J Marton | — |
Related Works
10Data: OpenAlex